Reuters logo
BRIEF-Voyager Therapeutics selects lead clinical candidate for Huntington's Disease
2017年6月1日 / 上午11点15分 / 4 个月前

BRIEF-Voyager Therapeutics selects lead clinical candidate for Huntington's Disease

June 1 (Reuters) - Voyager Therapeutics Inc:

* Voyager Therapeutics selects lead clinical candidate for Huntington’s Disease

* Voyager Therapeutics -preclinical pharmacology and toxicology studies are now underway with VY-htt01 to support filing of an IND application in 2018

* Voyager Therapeutics Inc says selection of VY-htt01, a clinical candidate for treatment of Huntington’s Disease Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below